Original article
SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis
Infección por SARS-CoV-2 y seroprevalencia en pacientes con esclerosis múltiple
Read
2388
Timeswas read the article
468
Total PDF
1920
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 22 | 2 | 24 |
| 2025 11 | 54 | 42 | 96 |
| 2025 10 | 50 | 12 | 62 |
| 2025 9 | 53 | 18 | 71 |
| 2025 8 | 31 | 16 | 47 |
| 2025 7 | 48 | 7 | 55 |
| 2025 6 | 43 | 7 | 50 |
| 2025 5 | 49 | 4 | 53 |
| 2025 4 | 29 | 5 | 34 |
| 2025 3 | 50 | 3 | 53 |
| 2025 2 | 58 | 5 | 63 |
| 2025 1 | 109 | 2 | 111 |
| 2024 12 | 31 | 6 | 37 |
| 2024 11 | 22 | 4 | 26 |
| 2024 10 | 23 | 7 | 30 |
| 2024 9 | 28 | 5 | 33 |
| 2024 8 | 24 | 3 | 27 |
| 2024 7 | 16 | 4 | 20 |
| 2024 6 | 24 | 1 | 25 |
| 2024 5 | 21 | 3 | 24 |
| 2024 4 | 19 | 15 | 34 |
| 2024 3 | 38 | 7 | 45 |
| 2024 2 | 33 | 7 | 40 |
| 2024 1 | 19 | 5 | 24 |
| 2023 12 | 29 | 7 | 36 |
| 2023 11 | 21 | 6 | 27 |
| 2023 10 | 39 | 7 | 46 |
| 2023 9 | 12 | 6 | 18 |
| 2023 8 | 9 | 7 | 16 |
| 2023 7 | 23 | 6 | 29 |
| 2023 6 | 23 | 10 | 33 |
| 2023 5 | 29 | 12 | 41 |
| 2023 4 | 21 | 6 | 27 |
| 2023 3 | 14 | 7 | 21 |
| 2023 2 | 28 | 4 | 32 |
| 2023 1 | 20 | 5 | 25 |
| 2022 12 | 39 | 4 | 43 |
| 2022 11 | 35 | 7 | 42 |
| 2022 10 | 31 | 8 | 39 |
| 2022 9 | 26 | 11 | 37 |
| 2022 8 | 36 | 15 | 51 |
| 2022 7 | 25 | 9 | 34 |
| 2022 6 | 40 | 16 | 56 |
| 2022 5 | 72 | 15 | 87 |
| 2022 4 | 74 | 16 | 90 |
| 2022 3 | 85 | 11 | 96 |
| 2022 2 | 51 | 7 | 58 |
| 2022 1 | 76 | 13 | 89 |
| 2021 12 | 50 | 15 | 65 |
| 2021 11 | 41 | 15 | 56 |
| 2021 10 | 21 | 13 | 34 |
| 2021 9 | 10 | 11 | 21 |
| 2021 8 | 22 | 2 | 24 |
| 2021 7 | 10 | 4 | 14 |
| 2021 6 | 14 | 3 | 17 |
Show all
